← back to database
Casdin Capital is a research-driven specialist investor focused on life sciences and healthcare innovation, including biotechnology, molecular medicine, synthetic biology, diagnostics, and enabling technologies. The firm invests across private-company stages as well as public markets.
Stage focus
Lead / follow
Specialization
Generalist / Specialist
Specialist
Investing team
Eileen MaysekResearch Analyst
Eli CasdinChief Investment Officer and Founder
Jack McGuireResearch Associate
Noah BurhanceResearch Associate
Ryan BlickerResearch Analyst
Shaun Rodriguez, PhDDirector of Life Science Research
Sriker Nadipuram, PharmDAnalyst
Suzanne AngellDirector of Therapeutics Research
Notable investments
23andMe, Adaptive Biotechnologies, Alector, Aledade, 908 Devices, AbSci, 4D Molecular Therapeutics